Bringing cervical cancer screen-and-treat services into HIV care for women
ACCESS: Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services
This project brings cervical cancer screening and same-day treatment into HIV clinics to better reach women living with HIV in Nigeria.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11404361 on NIH RePORTER |
What this research studies
If you are a woman living with HIV in Nigeria, this project would offer cervical cancer screening and, when needed, immediate treatment at the HIV clinics you already visit. The team partners with PEPFAR-supported HIV programs to adapt and test practical ways to deliver HPV testing/visual screening and same-day treatment. They will address clinic, community, and system barriers and track how many women are reached, treated, and followed over time. The aim is to find approaches that can be scaled up across regions to lower cervical cancer deaths.
Who could benefit from this research
Good fit: Adult women living with HIV who receive care at participating PEPFAR-supported HIV clinics in Nigeria are the intended participants.
Not a fit: Women who are HIV-negative, who do not attend participating clinics, or who live outside the program regions are unlikely to be eligible or benefit directly.
Why it matters
Potential benefit: If successful, this could catch and treat precancer earlier and reduce cervical cancer cases and deaths among women living with HIV.
How similar studies have performed: A pilot program in Nigeria showed this integrated screen-and-treat approach is feasible, but larger tailored strategies are still being tested for sustained scale-up.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Aarons, Gregory — University of California, San Diego
- Study coordinator: Aarons, Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.